A series of bicyclic isourea derivatives were prepared from 1-deoxynojirimycin using a concise synthetic protocol proceeding via a guanidino intermediate. Inhibition assays with a panel of glycosidases revealed that these deoxynojirimycin-derived bicyclic isoureas display very potent inhibition against human recombinant β-glucocerebrosidase with IC50 values in the low nanomolar range.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c6ob01735e | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!